Keyphrases
Glucagon-like
100%
Alzheimer's Disease
50%
Blood-brain
47%
Type 1 Diabetes Mellitus (T1DM)
47%
Hypoglycemia
45%
Type I Diabetes
36%
Brain Glucose
35%
GLP-1 Analogue
31%
Liraglutide
26%
Incretin Hormones
22%
Cerebral Glucose Metabolism
21%
Blood Flow
20%
Plasma Glucose
19%
Peripheral Neuropathy
18%
Myocardial Glucose Uptake
17%
Healthy Individuals
17%
Placebo
16%
Disease Effects
15%
Regional Cerebral Blood Flow (rCBF)
15%
Oral Administration
15%
Hexokinase
15%
Menten
15%
Human Brain
15%
Michaelis-Menten
15%
Neuroprotective
15%
Randomized Placebo-controlled Trial
15%
Non-invasive Measurement
15%
CAMP Response Element-binding Protein
15%
Metabolism
15%
Murine Model
15%
Clinically Significant
15%
N-acetylaspartate
15%
Brain Injury
15%
Neurodegeneration
15%
Double-blind Clinical Trial
15%
Working Memory
15%
Sitagliptin
15%
Brain Glucose Metabolism
15%
Double-blind Trial
15%
Randomized Crossover Trial
15%
CMRglc
15%
Neuroscience
Glucagon-Like Peptide-1
93%
Glucose Transport
58%
Metabolic Pathway
49%
Hypoglycemia
45%
Alzheimer's Disease
34%
Incretin
20%
Blood Plasma
19%
Neuroprotective Agent
18%
Cyclic Adenosine Monophosphate
15%
Neuropathy
15%
Spectroscopy
15%
Hexokinase
15%
Sitagliptin
15%
Brain Trauma
15%
Working Memory
15%
Traumatic Brain Injury
15%
Neurotrauma
15%
Protein Binding
15%
Neurodegeneration
15%
Response Element
15%
Medicine and Dentistry
Glucagon Like Peptide 1
34%
Glucose Metabolism
31%
Hypoglycemia
21%
Incretin
20%
Blood Flow
20%
Alzheimer's Disease
18%
Diseases
18%
Insulin Dependent Diabetes Mellitus
15%
Brain Blood Flow
15%
Neurodegeneration
15%
Liraglutide
15%
Sensorimotor Neuropathy
15%
Working Memory
15%
